|
Review of the distributed device manufacturing lot device history record for the reported event shows that all units were quality released to distribution on 01/24/2020 having met all internal qc acceptance requirements.Further review of subassembly lot shows that all sterilization cycle parameters, product bioburden, product lal and product sterility results met their respective acceptance criteria.There was one nonconformance associated with the subassembly manufacturing lot but investigation of nmr concluded no impact to the acceptability of this lot.In lieu of a request to the oem ecm supplier for dhr review, it is noted that aziyo biologics' processes utilize non-sterile materials which are further processed via cutting, suturing, packaging and sterilization.Further, as the exact cause of the reported event cannot be conclusively determined, should aziyo receive additional details from teh initial reporter, or our business partner, a supplemental report will be filed.
|